About Us   |   Services   |   Because I Care   |   Search   |   Careers   |   Awards   |   News   |   Contact Us   |   Join Now

Meritage Accountable Care Organization (ACO)

ACO Name and Location

Meritage ACO, LLC
4 Hamilton Lndg
Ste 100
Novato, California 94949

ACO Primary Contact

Primary Contact Name Marcy Norenius
Primary Contact Phone Number 415-884-1825
Primary Contact Email Address mnorenius@meritagemed.com

Organizational Information

ACO participants:

ACO Participants ACO Participant in Joint Venture (Enter Y or N)
Ronald J Botelho Ltd Y
Kathryn Najafi-Tagol, M.D. Y
Marin Gastroenterology Y
Soluna Health, Inc. Y
Curtis F. Robinson, M.D., Inc Y
Holly C. Kelly, M.D., Inc. Y
John D. Hollander, D.P.M., inc. Y
Santa Rosa Sports Medicine, Inc. Y
Darya Soto, MD Inc. Y
Daniel J. Solomon, Md Inc Y
Prima Medical Foundation Y
Sonoma Family Practice Y
Marin Nephrology Y
Marin Cancer Care, Inc. Y
Andrew Sawicki Y
Rachel Hoyal Dpm Inc A Professional Corporation Y
Richard E. Powers Y
Nancy Davidson, MD Y
First Med Marin Medical Clinic Y
Andrew Sawicki, D.P.M. Y
Francis T. Healy, M.D., F.C.C.P., A Prof Corp Y
Bart Gershbein, M.D. Y
Shan Kaur, M.D. Y
Thomas Fitzgerald, DPM Y
Mt. Tam Orthopedics, A Medical Center, Inc. Y
Brad Drexler, M.D. Y
Napa Valley Family Medical Group, Inc Y
Anesthesiology Cnslts of Marin A Med Grp In Y
Sonoma Valley Community Health Center Y
Dr. James Bryan Robison D.P.M. Y
Noah D. Weiss, M.D., Inc Y
J. Timothy Murphy, M.D. Y
Dominic Paul Amara, M.D. Y
Marin Hospitalist Medical Group, Inc. Y
Winthrop H. Hall, Jr., M.D. Y
Lizellen LaFollette, M.D. Y
Robert Harf Orthopaedics A Professional Corporation Y
Neurology Clinic of Marin, A Medical Corporation Y
John Andrew Y
John J. Jolley, M.D.A Professional Corporation Y
No. CA Minimally-Invasive Cardiovascular Surgery Inc. Y
Ross Valley Medical Corp. N
Nephrology Associates Y
Marin Healthcare District Y
Marin Medical Laboratories Y
J. Nevin Smith, M.D. Y
Santa Rosa Orthopaedic Medical Group Inc Y
Clinton Lane, M.D. Y
Randall Chapman, M.D., Inc. Y
San Francisco Foot and Ankle Center Y
Robert D Teasdale Jr Y
Robert L. Freinkel, M.D., Inc Y
Marin Ophthalmic Consultants, A Medical Corporation Y
Marin General Hospital Y
Hospice by the Bay Y
Eitan Homa Jennifer Krasnoff Y

 

ACO governing body:

Member Last Name Member First Name Member Title/Position Member’s Voting Power Membership Type ACO Participant TIN Legal Business Name/DBA, if Applicable
Chamberlin Keith Board Chair/President 1 vote Member 68-0265621
Habis Joseph Medical Director 1 vote Member 27-1376321
Johnson Ed Board Member 1 vote Medicare Beneficiary Representative n/a
Lane Clinton Secretary 1 vote Member 94-2613681
Wexman Mark Treasurer 1 vote Member 91-1886269
Friedenberg Jon Board Member 1 vote Member 19-32526860

Key ACO clinical and administrative leadership:

Mark Wexman ACO Executive
Joseph Habis Medical Director
Kim Noon Compliance Officer
Kim Noon Quality Assurance/Improvement Officer

Associated committees and committee leadership:

Committee Name Committee Leader Name and Position
Quality Improvement Committee Joseph Habis, MD (Medical Director)

Types of ACO participants, or combinations of participants, that formed the ACO:

  • Networks of individual practices of ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses

  • Second Agreement Period
    • Performance Year 2016, $0
  • First Agreement Period
    • Performance Year 2015, $0
    • Performance Year 2014, $0
    • Performance Year 2013, $0

Shared Savings Distribution

  • Second Agreement Period
    • Performance Year 2016
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
  • First Agreement Period
    • Performance Year 2015
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2014
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2013
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A

Quality Performance Results

2016 Quality Performance Results:

ACO# Measure Name Rate ACO Mean
ACO-1 CAHPS: Getting Timely Care, Appointments, and Information 82.7 79.9
ACO-2 CAHPS: How Well Your Providers Communicate 92.86 92.63
ACO-3 CAHPS: Patients’ Rating of Provider 91.9 91.93
ACO-4 CAHPS: Access to Specialists 82.24 83.52
ACO-5 CAHPS: Health Promotion and Education 61.64 60
ACO-6 CAHPS: Shared Decision Making 75.31 75.28
ACO-7 CAHPS: Health Status/Functional Status 76.14 71.82
ACO-34 CAHPS: Stewardship of Patient Resources 23.09 27.52
ACO-8 Risk-Standardized, All Condition Readmission 14.49 14.7
ACO-35 Skilled Nursing Facility 30-Day All-Cause Readmission Measure (SNFRM) 18.26 18.17
ACO-36 All-Cause Unplanned Admissions for Patients with Diabetes 40.24 53.2
ACO-37 All-Cause Unplanned Admissions for Patients with Heart Failure 60.97 75.23
ACO-38 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions 49.48 59.81
ACO-9 Ambulatory Sensitive Conditions Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5) 5.69 9.27
ACO-10 Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8 ) 14.03 14.53
ACO-11 Percent of PCPs who Successfully Meet Meaningful Use Requirements 76.27 82.72
ACO-39 Documentation of Current Medications in the Medical Record 79.58 87.54
ACO-13 Falls: Screening for Future Fall Risk 45.6 64.04
ACO-14 Preventive Care and Screening: Influenza Immunization 63.48 68.32
ACO-15 Pneumonia Vaccination Status for Older Adults 71.19 69.21
ACO-16 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow Up 62.63 74.45
ACO-17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention 93.81 90.98
ACO-18 Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan 40.43 53.63
ACO-19 Colorectal Cancer Screening 65.4 61.52
ACO-20 Breast Cancer Screening 81.31 67.61
ACO-21 Preventive Care and Screening: Screening for High Blood Pressure and Follow-up Documented 44.76 76.84
ACO-42 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease 70.81 77.72
ACO-27 Diabetes Mellitus: Hemoglobin A1c Poor Control 12.54 18.24
ACO-41 Diabetes: Eye Exam 39.43 44.94
ACO-28 Hypertension (HTN): Controlling High Blood Pressure 65.93 70.52
ACO-30 Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic 74.06 85.05
ACO-31 Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) 93.48 88.67
ACO-33 Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy – for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%) 71.33 79.67

 

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low samples.

Note: In the Quality Performance Results file(s) above, search for “Meritage ACO, LLC” to view the quality performance results. This ACO can also be found by using the ACO ID A82661 in the public use files on data.cms.gov.

Payment Rule Waivers

  • No, our ACO does not use the SNF 3-Day Rule Waiver.